About Team Pleryon
The Pleryon team is comprised of exceptional individuals with rich experience in innovation, product development, medical affairs and entrepreneurship. Our team works closely together, combining our expertise in biomaterial sciences, drug delivery, product development, and medicine to achieve our mission of developing novel polymer-based therapeutics to treat complex diseases.
Management Team
Yu Yu, PhD
Founder and Chief Excecutive Officer
Zhexun Sun, PhD
Cofounder and Chief Technology Officer
Andrew Luk, PhD
Vice President of Technology Translation
Prof. Ying Chau, PhD
Cofounder and Chief Scientific Officer
Charis Lau, PharmD, OD, MBA
Chief Medical Officer
Marylise Robert
Regulatory Responsible
David Enfrun
Quality Responsible
Simon Tsang, PhD
Business Development Advisor
Advisors
Scientia Professor at UNSW Sydney, leader in ocular surface diseases
Professor Fiona Stapleton
PhD, MCOptom, FAAO
Scientia Professor at UNSW Sydney, leader in ocular surface diseases
Prof. Lyndon Jones
DSc, FCOptom, FAAO
University Professor at the University of Waterloo, leader in ocular surface diseases
Prof. Ali Guermazi
MD, PhD
Professor of Radiology and Medicine at Boston University, leader in osteoarthritis
Prof. David Hunter
PhD, FRACP (Rheum)
Chair of Rheumatology at University of Sydney, leader in osteoarthritis
Board Members
Yu Yu, PhD
Founder and CEO
Stéphane Mendras
Independent
Ying Chau, PhD
Cofounder and CSO
Junhong Li
Lapam Captital
Yuchen Zhang, PhD
Efung Capital